Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price dropped 3.2% on Tuesday . The company traded as low as $0.77 and last traded at $1.21. Approximately 11,145 shares were traded during mid-day trading, an increase of 23% from the average daily volume of 9,053 shares. The stock had previously closed at $1.25.
Peak Pharmaceuticals Trading Down 3.2 %
The company’s 50-day moving average is $2.22 and its two-hundred day moving average is $2.97.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Further Reading
- Five stocks we like better than Peak Pharmaceuticals
- What is a Secondary Public Offering? What Investors Need to Know
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Bank Stocks – Best Bank Stocks to Invest In
- Insider Buying Signals Upside for These 3 Stocks
- Russell 2000 Index, How Investors Use it For Profitable Trading
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
